Hospitalized prevalence and 5-year mortality for IBD: record linkage study
- PMID: 20101767
- PMCID: PMC2811794
- DOI: 10.3748/wjg.v16.i4.431
Hospitalized prevalence and 5-year mortality for IBD: record linkage study
Abstract
Aim: To establish the hospitalized prevalence of severe Crohn's disease (CD) and ulcerative colitis (UC) in Wales from 1999 to 2007; and to investigate long-term mortality after hospitalization and associations with social deprivation and other socio-demographic factors.
Methods: Record linkage of administrative inpatient and mortality data for 1467 and 1482 people hospitalised as emergencies for > or = 3 d for CD and UC, respectively. The main outcome measures were hospitalized prevalence, mortality rates and standardized mortality ratios for up to 5 years follow-up after hospitalization.
Results: Hospitalized prevalence was 50.1 per 100 000 population for CD and 50.6 for UC. The hospitalized prevalence of CD was significantly higher (P < 0.05) in females (57.4) than in males (42.2), and was highest in people aged 16-29 years, but the prevalence of UC was similar in males (51.0) and females (50.1), and increased continuously with age. The hospitalized prevalence of CD was slightly higher in the most deprived areas, but there was no association between social deprivation and hospitalized prevalence of UC. Mortality was 6.8% and 14.6% after 1 and 5 years follow-up for CD, and 9.2% and 20.8% after 1 and 5 years for UC. For both CD and UC, there was little discernible association between mortality and social deprivation, distance from hospital, urban/rural residence and geography.
Conclusion: CD and UC have distinct demographic profiles. The higher prevalence of hospitalized CD in more deprived areas may reflect higher prevalence and higher hospital dependency.
Figures


Similar articles
-
Clostridium difficile co-infection in inflammatory bowel disease is associated with significantly increased in-hospital mortality.Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1041-1046. doi: 10.1097/MEG.0000000000001185. Eur J Gastroenterol Hepatol. 2018. PMID: 29894325
-
Crohn's disease and ulcerative colitis in England and the Oxford record linkage study area: a profile of hospitalized morbidity.Int J Epidemiol. 1995 Oct;24(5):922-8. doi: 10.1093/ije/24.5.922. Int J Epidemiol. 1995. PMID: 8557448
-
Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.Inflamm Bowel Dis. 2013 Mar-Apr;19(4):800-5. doi: 10.1097/MIB.0b013e3182802af7. Inflamm Bowel Dis. 2013. PMID: 23435402
-
Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.Inflamm Bowel Dis. 2017 Feb;23(2):218-223. doi: 10.1097/MIB.0000000000000993. Inflamm Bowel Dis. 2017. PMID: 27997435
-
Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020.Inflamm Bowel Dis. 2025 Jun 13;31(6):1574-1582. doi: 10.1093/ibd/izae184. Inflamm Bowel Dis. 2025. PMID: 39259598
Cited by
-
A Simple Noninvasive Score Predicts Disease Activity and Deep Remission in Ulcerative Colitis.Inflamm Intest Dis. 2018 Nov;3(1):16-24. doi: 10.1159/000490795. Epub 2018 Jul 24. Inflamm Intest Dis. 2018. PMID: 30505838 Free PMC article.
-
Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China.Front Public Health. 2021 Aug 20;9:704889. doi: 10.3389/fpubh.2021.704889. eCollection 2021. Front Public Health. 2021. PMID: 34490187 Free PMC article.
-
Effect of aqueous extract of Aegle marmelos unripe fruit on inflammatory bowel disease.Indian J Pharmacol. 2012 Sep-Oct;44(5):614-8. doi: 10.4103/0253-7613.100389. Indian J Pharmacol. 2012. PMID: 23112424 Free PMC article.
-
Inflammatory bowel disease in the elderly.Drugs Aging. 2010 Aug 1;27(8):617-24. doi: 10.2165/11537340-000000000-00000. Drugs Aging. 2010. PMID: 20658790 Review.
-
Perinatal and early life risk factors for inflammatory bowel disease.World J Gastroenterol. 2011 Feb 14;17(6):743-9. doi: 10.3748/wjg.v17.i6.743. World J Gastroenterol. 2011. PMID: 21390144 Free PMC article.
References
-
- Williams JG, Roberts SE, Ali MF, Cheung WY, Cohen DR, Demery G, Edwards A, Greer M, Hellier MD, Hutchings HA, et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut. 2007;56 Suppl 1:1–113. - PMC - PubMed
-
- Karlinger K, Györke T, Makö E, Mester A, Tarján Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol. 2000;35:154–167. - PubMed
-
- Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–1640. - PubMed
-
- Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004;3:394–400. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical